Shenzhen Kaifa Technology
920029
Shanghai Yongli Belting
300230
Guomai Culture & Media
301052
4
WuHan Hvsen Biotechnology
300871
5
CHANGFU CO.,LTD
871396
CN Stock MarketDetailed Quotes
300765 CSPC Innovation Pharmaceutical
- 37.00
- +0.31+0.84%
Market Closed Mar 28 15:00 CST
51.97BMarket Cap973.68P/E (TTM)
38.69High36.50Low120.22KlotVolume37.23Open36.69Pre Close455.01MTurnover0.96%Turnover Ratio973.68P/E (Static)1.40BShares40.0052wk High13.93P/B46.14BFloat Cap21.0752wk Low44.03Limit Up1.25BShs Float40.36Historical High29.35Limit Down5.97%Amplitude4.52Historical Low0.27Dividend TTM37.85Avg Price47.29KlotAsk0.72%Div YieldTTM100Lot Size63.40KlotBid
CSPC Innovation Pharmaceutical Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -76.87%872.08M | -59.15%1.29B | -48.90%1.48B | -4.04%2.69B | 71.71%3.77B | 96.62%3.17B | 98.07%2.9B | 64.56%2.8B | 76.44%2.2B | 19.45%1.61B |
| Transactional financial assets | --470.09M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -3.49%301.28M |
| Notes receivable and accounts receivable | -11.07%412.95M | 12.20%513.31M | -11.71%483.24M | -3.63%529.44M | -22.95%464.34M | -7.72%457.47M | 21.07%547.32M | 44.56%549.39M | 42.58%602.68M | 69.13%495.76M |
| -Notes receivable | 37.36%98.85M | 24.20%79.93M | -9.85%86.34M | -43.46%62.38M | -40.67%71.96M | -11.34%64.36M | 37.85%95.78M | 76.23%110.33M | 26.51%121.3M | -15.63%72.59M |
| -Accounts receivable | -19.95%314.1M | 10.24%433.37M | -12.10%396.89M | 6.38%467.06M | -18.49%392.38M | -7.10%393.12M | 18.02%451.54M | 38.31%439.06M | 47.30%481.38M | 104.34%423.17M |
| Other receivables (including interest and dividends) | 32.48%2.05M | 31.99%4.98M | -23.36%2.5M | -31.06%1.91M | -1.03%1.55M | 66.59%3.77M | 132.21%3.26M | 19.50%2.77M | 13.75%1.56M | 1.70%2.27M |
| -Other receivable | 32.48%2.05M | ---- | -23.36%2.5M | ---- | -1.03%1.55M | ---- | 132.21%3.26M | ---- | 13.75%1.56M | ---- |
| Contractual assets | ---- | --11.25M | --11.25M | --11.87M | --11.87M | ---- | ---- | ---- | ---- | ---- |
| Advance payment | -11.17%33.35M | 193.52%73.53M | 92.60%43.41M | 46.10%49.87M | 91.79%37.55M | -42.90%25.05M | 7.53%22.54M | 74.37%34.13M | 10.54%19.58M | 123.42%43.87M |
| Inventories | 77.33%398.67M | 26.93%321.24M | 34.38%300.9M | 14.37%262.04M | -5.59%224.82M | 21.14%253.08M | 6.14%223.91M | -12.45%229.12M | -9.11%238.13M | 20.22%208.9M |
| Receivable financing | 73.62%146.82M | -44.93%49.35M | -63.06%62.15M | -67.79%55.58M | -25.87%84.56M | 65.13%89.62M | 172.55%168.25M | 200.58%172.53M | 32.26%114.07M | 5.88%54.27M |
| Other current assets | 1,950.77%466.4M | 1,122.61%86.88M | 212.52%53.17M | 67.51%23.16M | 20.38%22.74M | -46.68%7.11M | -27.84%17.01M | -38.90%13.83M | -51.82%18.89M | -39.45%13.33M |
| Total current assets | -39.31%2.8B | -41.18%2.35B | -37.19%2.44B | -4.76%3.62B | 44.73%4.62B | 46.61%4B | 53.11%3.88B | 55.49%3.8B | 28.28%3.19B | 22.85%2.73B |
| Non Current assets | ||||||||||
| Long-term equity investment | -0.98%264.45M | 3.49%264.22M | 3.47%263.28M | 3.83%262.46M | 5.36%267.07M | 4.62%255.3M | 4.69%254.44M | 4.27%252.78M | 4.24%253.49M | 3.60%244.02M |
| Fixed assets | -1.70%2.05B | ---- | 115.97%2.05B | ---- | 111.57%2.08B | ---- | 107.45%947.4M | ---- | 56.04%984.02M | ---- |
| Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | ---- | --787.21K | ---- | ---- | ---- |
| Constru in process | 171.18%620.23M | ---- | 237.31%355.6M | ---- | 223.34%228.71M | ---- | -36.10%105.42M | ---- | -76.02%70.74M | ---- |
| Intangible assets | -2.75%225.21M | 366.46%226.81M | 363.91%228.4M | 361.64%229.99M | 359.33%231.59M | 19.06%48.62M | 19.03%49.23M | 18.94%49.82M | -4.53%50.42M | -4.06%40.84M |
| Deferred tax assets | 24.51%21.61M | 5.40%17.59M | -12.68%17M | -4.42%17.17M | -8.04%17.36M | -3.43%16.69M | 29.81%19.47M | 4.18%17.97M | 51.04%18.88M | 67.64%17.28M |
| Usufruct assets | -17.66%1.33M | -44.40%1.01M | -39.95%1.21M | --1.41M | --1.61M | 781.08%1.81M | 389.49%2.01M | ---- | ---- | -80.00%205.79K |
| Other non current assets | 53.00%40.29M | 4,041.79%383.41M | 3,276.90%535.51M | 69.38%20.29M | 65.57%26.33M | -49.92%9.26M | 4.46%15.86M | -15.70%11.98M | -16.56%15.9M | 74.42%18.48M |
| Total non current assets | 12.79%3.22B | 143.55%3.36B | 147.17%3.45B | 106.57%2.84B | 104.86%2.85B | 46.91%1.38B | 48.89%1.39B | 52.33%1.38B | 11.12%1.39B | 3.86%940.3M |
| Total assets | -19.41%6.02B | 6.22%5.72B | 11.54%5.89B | 24.83%6.47B | 63.01%7.47B | 46.68%5.38B | 51.97%5.28B | 54.63%5.18B | 22.53%4.58B | 17.35%3.67B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Notes payable and accounts payable | -68.66%396.21M | 394.99%409.95M | 126.07%311.07M | 171.00%392.97M | 607.37%1.26B | 24.51%82.82M | 197.61%137.6M | 143.64%145.01M | 38.39%178.75M | 0.51%66.51M |
| -Notes payable | --92.88M | --77.77M | --63.78M | --27.11M | ---- | ---- | ---- | ---- | --20M | ---- |
| -Accounts payable | -76.01%303.33M | 301.09%332.17M | 79.72%247.29M | 152.31%365.86M | 696.48%1.26B | 24.51%82.82M | 197.61%137.6M | 143.64%145.01M | 22.90%158.75M | 0.51%66.51M |
| Contract liabilities | -5.65%18.68M | 9.42%22.95M | -12.33%20.94M | -66.02%14.96M | -70.99%19.8M | -13.46%20.97M | 7.11%23.88M | 149.91%44.03M | 124.79%68.26M | 171.43%24.23M |
| Salaries payable | -17.05%28.45M | -14.27%25.71M | -4.99%27.04M | 17.71%30.24M | 7.74%34.29M | 67.78%29.99M | 98.98%28.46M | 79.90%25.69M | 19.32%31.83M | 41.25%17.88M |
| Taxs payable | -42.99%18.44M | -34.89%19.87M | -58.75%14.93M | -25.85%24.11M | -18.02%32.34M | -10.10%30.52M | 9.86%36.21M | 3.58%32.51M | 120.40%39.45M | 96.31%33.95M |
| Other payable (including interest and dividends) | 76.34%969.88M | 51.75%393.07M | 97.60%500.41M | 78.64%460.91M | 113.69%550M | 70.90%259.02M | 78.66%253.24M | 111.51%258.01M | 27.63%257.39M | 51.76%151.57M |
| -Other payable | 76.34%969.88M | ---- | 97.60%500.41M | ---- | 113.69%550M | ---- | 78.66%253.24M | ---- | 27.63%257.39M | ---- |
| Non current liabilities due within one year | 4.37%841.22K | 4.47%832.27K | -18.34%823.42K | 265.96%814.66K | 262.06%806K | 272.87%796.69K | 137.23%1.01M | -64.89%222.61K | -73.53%222.61K | -73.75%213.66K |
| Other current liabilities | -20.50%1.8M | 20.67%2.7M | -5.99%1.64M | -64.74%1.52M | -67.12%2.26M | 13.34%2.24M | 19.66%1.75M | 374.11%4.3M | 238.20%6.87M | 164.84%1.97M |
| Total current liabilities | -24.67%1.43B | 105.25%875.08M | 81.86%876.86M | 81.56%925.52M | 226.70%1.9B | 43.88%426.35M | 85.86%482.15M | 106.95%509.76M | 42.61%582.77M | 43.51%296.32M |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | --19.7M | --19.7M | --19.8M | ---- |
| Deferred tax liabilities | 5,680.21%1.4M | 973.63%500.22K | -51.36%25.63K | -62.58%24.29K | -62.58%24.29K | -83.71%46.59K | -74.60%52.7K | -88.50%64.91K | -90.33%64.91K | -52.57%286K |
| Long term deferred income | 7.52%90.49M | 155.19%94.4M | 151.03%91.04M | 70.53%63.16M | 126.18%84.16M | 21.25%36.99M | 16.58%36.26M | 16.49%37.04M | 8.59%37.21M | -3.50%30.51M |
| Lease liabilities | ---- | -79.56%213.69K | -65.94%425.11K | --634.27K | --841.22K | --1.05M | --1.25M | ---- | ---- | ---- |
| Total non current liabilities | 8.08%91.89M | 149.74%95.12M | 59.76%91.49M | 12.36%63.82M | 48.97%85.02M | 23.67%38.09M | 82.87%57.27M | 75.54%56.8M | 63.37%57.07M | -5.10%30.8M |
| Total liabilities | -23.27%1.53B | 108.90%970.19M | 79.52%968.34M | 74.62%989.34M | 210.85%1.99B | 41.98%464.44M | 85.54%539.41M | 103.30%566.57M | 44.25%639.84M | 36.90%327.12M |
| Shareholders equity | ||||||||||
| Paid-in capital | 19.97%1.4B | 19.97%1.4B | 19.97%1.4B | 80.00%1.17B | 89.16%1.17B | 114.42%1.17B | 114.42%1.17B | 19.12%650.41M | 13.36%618.93M | 0.00%546M |
| Capital reserve funds | -54.00%977.27M | -13.64%975.5M | -9.24%975.5M | -24.54%1.2B | 86.63%2.12B | 49.36%1.13B | 42.12%1.07B | 110.93%1.6B | -6.03%1.14B | 0.00%756.28M |
| Surplus reserve funds | 19.91%339.22M | 15.11%329.08M | 25.46%321.79M | 27.47%282.89M | 27.47%282.89M | 81.69%285.88M | 39.73%256.49M | 41.04%221.93M | 41.04%221.93M | 2.41%157.35M |
| Retained profit | -22.10%1.33B | -38.71%1.42B | -35.76%1.43B | -16.35%1.79B | -12.82%1.7B | 23.93%2.32B | 31.76%2.22B | 33.21%2.14B | 42.14%1.96B | 31.56%1.87B |
| Less:Treasury stock | 7,457.34%321.03M | --321.03M | --226.99M | --39.24M | --4.25M | ---- | ---- | ---- | ---- | ---- |
| Other composite income | 25.78%2.5M | -12.68%1.48M | -33.57%1.6M | 168.55%1.61M | 175.86%1.98M | 177.69%1.7M | 419.99%2.41M | 169.74%600.26K | 159.85%719.36K | 209.18%611.19K |
| Shareholders equity without minority interests | -29.36%3.73B | -22.35%3.81B | -17.41%3.91B | -4.30%4.41B | 34.18%5.28B | 47.26%4.91B | 49.02%4.73B | 50.34%4.61B | 19.65%3.94B | 15.78%3.33B |
| Minority interests | 278.07%765.39M | 10,742.73%934.81M | 11,434.77%1.01B | 12,420.67%1.07B | 2,255.81%202.45M | 0.48%8.62M | 3.70%8.77M | 3.70%8.55M | 4.04%8.59M | -0.30%8.58M |
| Total shareholder equity | -18.01%4.5B | -3.48%4.75B | 3.80%4.92B | 18.72%5.48B | 39.02%5.48B | 47.14%4.92B | 48.90%4.74B | 50.22%4.61B | 19.61%3.94B | 15.73%3.34B |
| Total liabilityies and equity | -19.41%6.02B | 6.22%5.72B | 11.54%5.89B | 24.83%6.47B | 63.01%7.47B | 46.68%5.38B | 51.97%5.28B | 54.63%5.18B | 22.53%4.58B | 17.35%3.67B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.